CD34 and plasma cell myeloma: In vivo studies conducted in irradiated NOD/SCID mice, which were simultaneously injected with CD34+ HSC and myeloma cells indicated that the occupation of HSC in the BM niche decreased as the number of myeloma cells injected increased (35).